n this browser, the site may not be displayed correctly. We recommend that You install a more modern browser.

Chrome Safari Firefox Opera IE  


  • 5 June 2023

    This survey is focused on licensing regulations in Russia. The questions were drafted to cover areas of potential deviation from expected norms in respect to core licensing terms (i.e., the basic grant of rights, payment, and termination, as well as registration).

    All Publications
«Gorodissky» in media
  • 3 February 2021

    Sergey Medvedev, Partner at Gorodissky & Partners, gave the following comment to  Practical Law by Thomson Reuters on what to expect in 2021 in Pharma: “The use of the patented technologies and inventions for the benefit of national security in the pharma sphere should become a hot issue. The Russian government has already issued a binding order under Article 1360 of the Russian Civil Code to allow the use of inventions related to the production of Remdesivir...

    All «Gorodissky» in media
Legal updates